• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    BELLUS Health Inc. - Common Shares (NQ: BLU )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EDT, Jun 28, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open -
    Bid (Size) 14.73 (50)
    Ask (Size) 14.75 (36)
    Prev. Close 14.74
    Today's Range N/A - N/A
    52wk Range N/A - N/A
    Shares Outstanding 55,378,660
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs
    Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments. This significant financial reserve will be crucial as... 
    Via Benzinga
    BELLUS Health Inc. Announces Voting Results from Special Meeting of Shareholders
    From BELLUS Health Inc.
    Via Business Wire

    Performance

    More News

    Read More
    The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
    Via Investor's Business Daily
    BELLUS Health: Q1 Earnings Insights
    Via Benzinga
    GSK Stock: A Value Trap or a Hidden Gem?
    Via InvestorPlace
    BELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition
    From BELLUS Health Inc.
    Via Business Wire
    BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights
    From BELLUS Health Inc.
    Via Business Wire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ruth’s Inc. (Nasdaq – RUTH), Magenta Therapeutics, Inc. (Nasdaq – MGTA), BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Where BELLUS Health Stands With Analysts
    Via Benzinga
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq – SPPI), BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX), Univar Solutions Inc. (NYSE - UNVR)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    BELLUS Health Announces Meeting Updates
    From BELLUS Health Inc.
    Via Business Wire
    BELLUS Health Inc. (NASDAQ: BLU) Leading the Way in Tuesday Trading Based on Percentage Gain
    Via Investor Brand Network
    3 Biotechs That Might Get Bought Out in 2023
    Via The Motley Fool
    Was This Acquisition a Savvy Play by This Big Pharma Stock?
    Via The Motley Fool
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq – SPPI), BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX), Univar Solutions Inc. (NYSE – UNVR)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Second Quarter Outlook For Biotech Stocks
    Via Talk Markets
    Why This Nasdaq Stock Caught Fire This Week
    Via The Motley Fool
    Why Shares of Bellus Health Skyrocketed This Week
    Via The Motley Fool
    Dow Edges Higher; Goldman Sachs Posts Upbeat Earnings
    Via Benzinga
    GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health
    From BELLUS Health Inc.
    Via Business Wire
    Benzinga's Top Ratings Upgrades, Downgrades For April 19, 2023
    Via Benzinga
    Dow Dips Over 100 Points; Bank of America Earnings Beat Estimates
    Via Benzinga
    Why BELLUS Health Stock Is Rocketing Higher Today
    Via The Motley Fool
    Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2023
    Via Benzinga
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.